CMS Could Increase Access To Non-Pharmacological Pain Treatments, US Congress Report Says
Executive Summary
A majority of providers, payers, device companies and others with a stake in opioid treatment and substance use disorder surveyed by lawmakers told the US House Ways and Means Committee that public insurers such as Medicare need to increase access to non-pharmacological and non-opioid treatments for pain, according to a congressional whitepaper on opioids.